Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics

In the field of nuclear medicine, the β(+) -emitting (43)Sc and β(−) -emitting (47)Sc are promising candidates in cancer diagnosis and targeted radionuclide therapy (TRT) due to their favorable decay schema and shared pharmacokinetics as a true theranostic pair. Additionally, scandium is a group-3 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Meier, Jason P., Zhang, Hannah J., Freifelder, Richard, Bhuiyan, Mohammed, Selman, Phillip, Mendez, Megan, Kankanamalage, Pavithra H. A., Brossard, Thomas, Pusateri, Antonino, Tsai, Hsiu-Ming, Leoni, Lara, Penano, Sagada, Ghosh, Kaustab, Broder, Brittany A., Markiewicz, Erica, Renne, Amy, Stadler, Walter, Weichselbaum, Ralph, Nolen, Jerry, Kao, Chien-Min, Chitneni, Satish K., Rotsch, David A., Szmulewitz, Russell Z., Chen, Chin-Tu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458970/
https://www.ncbi.nlm.nih.gov/pubmed/37630292
http://dx.doi.org/10.3390/molecules28166041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458970/
https://www.ncbi.nlm.nih.gov/pubmed/37630292
http://dx.doi.org/10.3390/molecules28166041

Ejemplares similares